论文部分内容阅读
目的观察埃索美拉唑联合硫糖铝混悬液治疗反流性食管炎临床疗效观察.方法62例经胃镜检查确诊为反流性食管炎的患者随机分为治疗组和对照组,两组均口服埃索美拉唑40 mg,2次/每天,莫沙必利分散片5 mg,3次/每天;治疗组联合硫糖铝混悬液口服10 ml/次,4次/d,治疗4周.结果治疗后两组患者临床症状及胃镜结果均明显好转,治疗组优于对照组(P<0.05).结论埃索美拉唑联合硫糖铝混悬液治疗反流性食管炎有良好的协同作同,安全有效.“,”Objective To observe clinical curative effects on reflux esophagitis patients after Esomeprazole and Sucralfate suspension. Methods:Divided the 62 patients diagnosed as RE by gastroscopy into two groups:treatment group and control group, they al received oral Esomeprazole 40mg,twice a day,Mosapride dispersible tablets 5mg, three times; treatment group received additional oral Sucralfate suspension 10ml,four times a day,lasting for 4 weeks. Results the clinical symptoms and gastroscopy results of two groups were significantly improved,the treatment group was better than control group(P<0.05). Conclusion Esomeprazole combined with Sucralfate suspension in the treatment of reflux esophagitis worked wel,safe and effective.